Cargando…
Cytomegalovirus vaccines under clinical development
Congenital cytomegalovirus (CMV) infection is the most common infectious cause of disability in newborn infants. CMV also causes serious disease in solid organ (SOT) and haematopoietic stem cell transplant (HSCT) recipients. In otherwise healthy children and adults, primary CMV infection rarely caus...
Autor principal: | Schleiss, Mark R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075346/ https://www.ncbi.nlm.nih.gov/pubmed/27781101 |
Ejemplares similares
-
Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
por: Schleiss, Mark R.
Publicado: (2013) -
Prevention of maternal cytomegalovirus infection: current status and future prospects
por: Nyholm, Jessica L, et al.
Publicado: (2010) -
Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection
por: Schleiss, Mark R., et al.
Publicado: (2020) -
Development and Assessment of a Prenatal Cytomegalovirus (CMV) Educational Survey: Implementation and Impact in a Metropolitan University-Based Clinic
por: Schaefer, Malinda R, et al.
Publicado: (2020) -
Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening
por: Tastad, Katie J., et al.
Publicado: (2019)